Rybelsus (Semaglutide Tablets)
£260.00
Rybelsus is a once-daily tablet containing Semaglutide. It is licensed for type 2 diabetes and can be prescribed off-label for weight loss for those who prefer to take tablets instead of injections.
Rybelsus is the first oral GLP-1 receptor agonist, containing the active ingredient semaglutide. It is prescribed for adults who are overweight or living with obesity, and works by mimicking the natural hormone GLP-1 to regulate appetite and blood sugar levels. By helping you feel fuller for longer, Rybelsus supports portion control and sustainable weight loss when combined with a healthy diet and exercise plan.
Key Details:
-
Form: Oral tablet
-
Active Ingredient: Semaglutide
-
Use: Weight management (prescription-only)
-
Dosage: Once daily, as prescribed by a healthcare professional
-
Best results: Achieved alongside balanced diet & regular activity
How It Works:
Rybelsus acts on GLP-1 receptors in the brain and digestive system to:
-
Reduce appetite and cravings
-
Help regulate blood sugar levels
-
Support steady, sustainable weight loss
| Strength |
3mg Rybelsus (starting dose) ,7mg Rybelsus (titration dose) ,14mg Rybelsus (maintenance dose) |
|---|
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Related products
